Shares of Healthways Inc. (NASDAQ:HWAY) were up 3% on Wednesday . The stock traded as high as $24.96 and last traded at $24.30, with a volume of 836,645 shares traded. The stock had previously closed at $23.59.

Several analysts have recently weighed in on HWAY shares. FBR & Co reissued a “buy” rating on shares of Healthways in a report on Friday, April 29th. Barrington Research decreased their price objective on Healthways from $15.00 to $14.00 and set an “outperform” rating on the stock in a report on Friday, April 29th. Jefferies Group reissued a “hold” rating and set a $13.00 price objective on shares of Healthways in a report on Tuesday, May 3rd. Zacks Investment Research raised Healthways from a “sell” rating to a “hold” rating in a report on Tuesday, May 3rd. Finally, Piper Jaffray Cos. raised their target price on Healthways from $15.00 to $25.50 and gave the stock an “overweight” rating in a research report on Wednesday, August 10th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $19.71.

The stock’s 50-day moving average is $14.78 and its 200 day moving average is $12.21. The firm’s market capitalization is $887.59 million.

Healthways (NASDAQ:HWAY) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.53. The business earned $125 million during the quarter, compared to the consensus estimate of $186.88 million. Healthways’s quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.11 EPS. Analysts expect that Healthways Inc. will post $1.08 earnings per share for the current year.

A hedge fund recently raised its stake in Healthways stock. BNP Paribas Arbitrage SA raised its stake in shares of Healthways Inc. (NASDAQ:HWAY) by 37.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 80,127 shares of the company’s stock after buying an additional 21,702 shares during the period. BNP Paribas Arbitrage SA owned approximately 0.22% of Healthways worth $1,031,000 as of its most recent SEC filing.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.